Cue Biopharma, Inc.
Pharmaceutical company · Boston, Massachusetts, United States · Nasdaq: CUE
Cue Biopharma, Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2014. Its shares trade on Nasdaq under the ticker CUE. It has reported private securities offerings to the US SEC, most recently $30 million sold in a notice filed in 2026.
Cue Biopharma at a glance
What does Cue Biopharma do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $30 million sold (2026).
Frequently asked questions about Cue Biopharma
Where is Cue Biopharma headquartered?
Cue Biopharma, Inc. is headquartered in Boston, Massachusetts, United States.
What does Cue Biopharma do?
Cue Biopharma, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Cue Biopharma a public company?
Yes. Cue Biopharma, Inc. trades on Nasdaq under the ticker CUE.
When was Cue Biopharma founded?
The earliest incorporation on record for Cue Biopharma, Inc. is in 2014, according to public company registers.
Similar companies
- Transcode Therapeutics, Inc.Boston, Massachusetts, United States
- Akouos, Inc.Boston, Massachusetts, United States
- Astria Therapeutics, Inc.Boston, Massachusetts, United States
- Albireo Pharma, Inc.Boston, Massachusetts, United States
- Atea Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Rhythm Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Tango Therapeutics, Inc.Boston, Massachusetts, United States
- Paratek Pharmaceuticals, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.